glp-1 research papers Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine GLP-1 Genetics: How Genes Affect
Description
The reality is that the research really isnt super clear yet
You must be logged in to post a comment.
According to the FDA's press release it agreed to approve the drug for obesity based on three randomised, double-blind, placebo-controlled trials during which more than 2,600 patients received Wegovy for up to 68 weeks and more than 1,500 patients received placebo (US FDA 2021)
REMEMBER: Do not take an extra dose or increase the dose to make up for a missed dose
During this meeting, attorneys will talk about the cases progress and the next steps
The implications are straightforward
